Neoadjuvant hormone therapy for patients with high-risk prostate cancer: a systematic review and meta-analysis

Neoadjuvant hormone therapy for patients with high-risk prostate cancer: a systematic review and meta-analysis

This study aimed to identify the pathological outcomes and survival benefits of neoadjuvant hormone therapy (NHT) combined with radical prostatectomy (RP) and radiotherapy (RT) administered to patients with high-risk prostate cancer (HRPCa). We searched PubMed, Embase, and the Cochrane Library for s...

Full description

Bibliographic Details
Main Authors:	Wen Liu, Yu Yao, Xue Liu, Yong Liu, Gui-Ming Zhang
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2021-01-01
Series:	Asian Journal of Andrology
Subjects:	high-risk diseases; meta-analysis; neoadjuvant hormone therapy; prostate cancer; prostatectomy; radiotherapy
Online Access:	http://www.ajandrology.com/article.asp?issn=1008-682X;year=2021;volume=23;issue=4;spage=429;epage=436;aulast=Liu

Similar Items

The Impact of Neoadjuvant Hormone Therapy on Surgical and Oncological Outcomes for Patients With Prostate Cancer Before Radical Prostatectomy: A Systematic Review and Meta-Analysis
by: Lijin Zhang, et al.
Published: (2021-02-01)

Neoadjuvant hormonal therapy is a feasible option in laparoscopic radical prostatectomy
by: Naiki Taku, et al.
Published: (2012-12-01)

Pathologic response to neoadjuvant therapy of high risk prostate cancer
by: M. V. Berkut, et al.
Published: (2020-11-01)

Neoadjuvant Chemohormonal Therapy before Radical Prostatectomy for Japanese Patients with High-Risk Localized Prostate Cancer
by: Takeshi Sasaki, et al.
Published: (2021-04-01)

Oncological results of neoadjuvant chemohormonal therapy in patients with high and very high-risk prostate cancer
by: M. V. Berkut, et al.
Published: (2020-04-01)

The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis
by: Zhipeng Wang, et al.
Published: (2020-02-01)

The role of radical prostatectomy in high-risk prostate cancer
by: Byung Ha Chung
Published: (2013-09-01)

Radical Prostatectomy is a Valuable Treatment Alternative in Patients with High-Risk Prostate Cancer
by: Naşide Mangır, et al.
Published: (2015-09-01)

The role of radical prostatectomy and definitive external beam radiotherapy in combined treatment for high-risk prostate cancer: a systematic review and meta-analysis
by: Xu Cheng, et al.
Published: (2020-01-01)

Short-term benefit of neoadjuvant hormone therapy in patients with localized high-risk or limited progressive prostate cancer
by: Ma BL, et al.
Published: (2019-05-01)

Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review
by: Alessandro Sciarra, et al.
Published: (2016-11-01)

Perineural invasion as an independent predictor of biochemical recurrence in prostate cancer following radical prostatectomy or radiotherapy: a systematic review and meta-analysis
by: Li-jin Zhang, et al.
Published: (2018-02-01)

Early stage prostate cancer: biochemical recurrence after treatment
by: Danielle A. Zanatta, et al.
Published: (2014-04-01)

Predictors of prostate volume reduction following neoadjuvant cytoreductive androgen suppression
by: Krishan R. Jethwa, et al.
Published: (2016-11-01)

Radical prostatectomy for high-risk prostate cancer | Opinion: NO
by: Saum Ghodoussipour, et al.

Radical prostatectomy for high-risk prostate cancer | Opinion: YES
by: Leonardo O. Reis, et al.

Combined Modality Therapies for High-Risk Prostate Cancer: Narrative Review of Current Understanding and New Directions
by: Benjamin A. Greenberger, et al.
Published: (2019-11-01)

The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer
by: Jongchan Kim, et al.
Published: (2017-09-01)

Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics?
by: Gustavo Arruda Viani, et al.

Editorial: Controversies and Perspectives in the Use of Postoperative Radiotherapy for Prostate Cancer
by: Alan Dal Pra, et al.
Published: (2017-11-01)

Radical prostatectomy vs radiotherapy in high-risk prostate cancer patients: two centre experience
by: Albertas Ulys, et al.
Published: (2015-01-01)

First experiment study in cytoreductive prostatectomy in patients with oligo-metastatic prostate cancer following neoadjuvant chemohormonotherapy
by: V. O. Mager, et al.
Published: (2021-07-01)

Analysis of the Curative Effect of Neoadjuvant Therapy on Pancreatic Cancer
by: Liqiong Yang, et al.
Published: (2021-08-01)

Brachytherapy Combined With or Without Hormone Therapy for Localized Prostate Cancer: A Meta-Analysis and Systematic Review
by: Xueliang Zhou, et al.
Published: (2020-02-01)

Efficiency of application of radiation techniques to treat patients with localized prostate cancer in one hospita
by: E. A. Kipriyanov, et al.
Published: (2017-06-01)

Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy
by: Yong Jin Kang, et al.
Published: (2017-11-01)

Comparative Survival Outcomes of High-risk Prostate Cancer Treated with Radical Prostatectomy or Definitive Radiotherapy Regimens
by: Kirsti Aas, et al.
Published: (2021-04-01)

BEAM THERAPY AND LONG-TERM HORMONAL THERAPY IN PATIENTS WITH PROSTATE CANCER
by: A. O. Karyakin, et al.
Published: (2014-07-01)

BEAM THERAPY AND LONG-TERM HORMONAL THERAPY IN PATIENTS WITH PROSTATE CANCER
by: A. O. Karyakin, et al.
Published: (2014-07-01)

RADICAL PROSTATECTOMY WITH EXTENDED PELVIC LYMPHADENECTOMY AND ADJUVANT HORMONAL THERAPY IN PATIENTS WITH LYMPHOGENIC DISSEMINATED PROSTATE CANCER
by: B. Ya. Alekseev, et al.
Published: (2014-08-01)

RADICAL PROSTATECTOMY WITH EXTENDED PELVIC LYMPHADENECTOMY AND ADJUVANT HORMONAL THERAPY IN PATIENTS WITH LYMPHOGENIC DISSEMINATED PROSTATE CANCER
by: B. Ya. Alekseev, et al.
Published: (2014-08-01)

Critical analysis of salvage radical prostatectomy in the management of radioresistant prostate cancer
by: Daniel Seabra, et al.
Published: (2009-02-01)

Results of a unicenter randomized study of the safety and efficiency of docetaxel chemotherapy before radical prostatectomy in patients with intermediate- and high-risk prostate cancer: An 11.4-year follow-up
by: A. K. Nosov, et al.
Published: (2014-12-01)

Results of a unicenter randomized study of the safety and efficiency of docetaxel chemotherapy before radical prostatectomy in patients with intermediate- and high-risk prostate cancer: An 11.4-year follow-up
by: A. K. Nosov, et al.
Published: (2014-12-01)

Neoadjuvant chemotherapy in high-risk localized prostate cancer: a systematic review
by: Hamidreza Mirzaei, et al.
Published: (2020-02-01)

High prevalence of secondary bladder cancer in men on radiotherapy for prostate cancer: evidence from a meta-analysis
by: Zhao S, et al.
Published: (2019-01-01)

Radical exenteration surgery is curative in locally advance mucinous prostatic adenocarcinoma involving bladder and rectum
by: Vincent S W Koo, et al.
Published: (2010-06-01)

Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study
by: Fundagul Andic, et al.
Published: (2019-01-01)

Efficacy of Definitive External-beam Radiotherapy Versus Radical Prostatectomy on Clinically Localized High-risk Prostate Cancer Patients: A Retrospective Study
by: DENG Kangli, et al.
Published: (2019-12-01)

HORMONE AND RADIATION THERAPY IN HIGH- AND VERY HIGH-RISK PATIENTS WITH PROSTATE CANCER
by: A. O. Karyakin, et al.
Published: (2014-08-01)

Cannot write session to /tmp/vufind_sessions/sess_b09j71c63bnrkv3iag95viuj03